LTS Lohmann Therapie-Systeme AG
Contract developer and manufacturer of non-invasive drug delivery systems and combination products. Offers end-to-end CDMO services for transdermal patches, topical patches, oral thin films, dissolvable microneedle patches and on-body delivery systems, including API evaluation, formulation development, prototyping, clinical trial supply, scale-up and commercial manufacture across multiple global sites. Maintains dedicated R&D laboratories for permeation testing and analytical support and reports site-level sustainability and quality management commitments.
Industries
N/A
Products
Transdermal therapeutic systems (patches)
Transdermal patch platforms for systemic and local delivery of active substances with scalable production capability.
Oral thin films
Orally dissolving thin film formulations for rapid or convenient delivery of active ingredients via the buccal/oral mucosa.
Dissolvable microneedle (microarray) patches
Microneedle patch products designed for intradermal delivery with potential applications in vaccines, biologics and small molecules.
On-body delivery systems and wearable injectors
On-body delivery platforms supporting dose volumes from point-of-care small-volume loading to larger pre-filled configurations, designed for programmable infusion and patient-centred use.
Transdermal therapeutic systems (patches)
Transdermal patch platforms for systemic and local delivery of active substances with scalable production capability.
Oral thin films
Orally dissolving thin film formulations for rapid or convenient delivery of active ingredients via the buccal/oral mucosa.
Dissolvable microneedle (microarray) patches
Microneedle patch products designed for intradermal delivery with potential applications in vaccines, biologics and small molecules.
On-body delivery systems and wearable injectors
On-body delivery platforms supporting dose volumes from point-of-care small-volume loading to larger pre-filled configurations, designed for programmable infusion and patient-centred use.
Services
End-to-end CDMO services for non-invasive dosage forms
Integrated services including API evaluation, feasibility studies, formulation development, prototyping, clinical trial supply, scale-up and commercial manufacture for transdermal, topical, oral film, microneedle and device products.
In vitro permeation testing and analytical support (Skin Lab)
IVPT and permeation studies designed and executed according to OECD, FDA and EMA guidance, including GMP-certified IVPT and analytical workflows to support formulation optimisation and regulatory submissions.
Device technologies development and manufacturing
Development and manufacture of drug-device combination products, including on-body delivery systems, wearable injectors and support for high-viscosity formulations and sterile filling workflows.
End-to-end CDMO services for non-invasive dosage forms
Integrated services including API evaluation, feasibility studies, formulation development, prototyping, clinical trial supply, scale-up and commercial manufacture for transdermal, topical, oral film, microneedle and device products.
In vitro permeation testing and analytical support (Skin Lab)
IVPT and permeation studies designed and executed according to OECD, FDA and EMA guidance, including GMP-certified IVPT and analytical workflows to support formulation optimisation and regulatory submissions.
Device technologies development and manufacturing
Development and manufacture of drug-device combination products, including on-body delivery systems, wearable injectors and support for high-viscosity formulations and sterile filling workflows.
Expertise Areas
- Transdermal drug delivery
- Topical patch systems and hot-melt adhesives
- Oral thin film development
- Dissolvable microneedle (microarray) patches
Key Technologies
- Transdermal therapeutic systems (patch coating and conversion)
- Hot-melt adhesive topical patch technology
- Oral thin film manufacturing
- Dissolvable microarray (microneedle) patches